healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Evidence
integrate_iia_2025_rct_regorafenib-vs-placebo-in-advanced-gastric-cancer
5 findings
Protocol
medication-regorafenib-supportive-care
Outcome
qol-global-quality-of-life-time-to-deterioration-hazard-ratio
n
169
effect
60
attribution
85
Protocol
medication-regorafenib-supportive-care
Outcome
survival-overall-12-month-rate-percent
n
169
effect
70
attribution
85
Protocol
medication-regorafenib-supportive-care
Outcome
survival-overall-hazard-ratio-compared-to-placebo
n
169
effect
65
attribution
85
Protocol
medication-regorafenib-supportive-care
Outcome
survival-overall-median-duration-months
n
169
effect
20
attribution
85
Protocol
medication-regorafenib-supportive-care
Outcome
survival-progression-free-hazard-ratio-compared-to-placebo
n
169
effect
75
attribution
85